The Venture Codex Logo

The Venture Codex

DNA Capital

Rua Joaquim Floriano, 72 - 201, São Paulo, SP, 04534-010, Brazil

Overview

Investment partnership specializing in healthcare sector investments.

Founded

2013

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

Brazil
China
United States

Sector focus

—

Investment portfolio

9rounds
NAMEDATESIZE
Memed
May 2026Participated
$16 MOther Equity
Reema Health
Apr 2022Led
$8 MSeed
Inspirali
Apr 2022Led
$211 MOther Equity
Nice Healthcare
Mar 2022Led
$30 MSeries A
Beep Saúde
Apr 2021Participated
$19 MSeries B
Vitable Health
Oct 2020Participated
$2 MOther Equity
Memed
Feb 2020Led
$5 MSeries B
The CareVoice
Aug 2019Participated
$10 MSeries A
Arterys
Nov 2017Participated
$30 MSeries B
Memed
May 2026Participated
$16 MOther Equity
Reema Health
Apr 2022Led
$8 MSeed
Inspirali
Apr 2022Led
$211 MOther Equity
Nice Healthcare
Mar 2022Led
$30 MSeries A
Beep Saúde
Apr 2021Participated
$19 MSeries B
Vitable Health
Oct 2020Participated
$2 MOther Equity
Memed
Feb 2020Led
$5 MSeries B
The CareVoice
Aug 2019Participated
$10 MSeries A
Arterys
Nov 2017Participated
$30 MSeries B
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

DNA Capital: 9 funding rounds are recorded in the selected participation categories.All available history.
DNA Capital: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series A11
Series B12
Other Equity12

Monthly Deal Activity

DNA Capital: 9 deals are recorded across 108 months.All available history.
DNA Capital: 9 deals are recorded across 108 months. All available history
MonthDeals
Nov '171
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '191
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '201
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '201
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '211
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '221
Apr '222
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

DNA Capital: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

DNA Capital: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
Fintech2
Enterprise Software2
Education & Workforce1
Social & Community Platforms1

Deal Size Distribution

DNA Capital: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

DNA Capital: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M1
$10M-$25M3
$25M-$50M2
$50M-$100M0
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

DNA Capital: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

DNA Capital: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Brazil4
China1
DNA Capital: 20 co-investors are shown, with Artesian sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

DNA Capital: 20 co-investors are shown, with Artesian sharing 1 recorded deals. All available history
Co-investorShared deals
Artesian1
Banco Bradesco1
Bridge One1
Brown Venture Group1
Commerce Ventures1
Conductive Ventures1
Coughdrop Capital1
DGF Investimentos1
Emergent Medical Partners1
Endeavor Catalyst1
F. R. Bigelow Foundation1
Fosun1
GE Ventures1
LUN Partners Group1
MaC Venture Capital1
MSA Capital1
NewYork-Presbyterian Hospital1
Northwell Ventures1
ORI Healthcare Fund1
Redpoint eventures1

Investment Strategy

DNA Capital: Led accounts for 44% and participating for 56% of round participation.All available history.
DNA Capital: Led accounts for 44% and participating for 56% of round participation. All available history
CategoryDeals (count)Share (%)
Led444%
Participating556%
DNA Capital: Single-lead accounts for 75% and co-led for 25% of lead dynamics.All available history.
DNA Capital: Single-lead accounts for 75% and co-led for 25% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead375%
Co-led125%

Team

José Eduardo Ribeiro Guinle

Partner

Luiz Felipe D Martins Costa

Managing Partner

Luiz Noronha

Partner

Mario Sergio Ribeiro

Partner

Partha Mishra

Partner

Thayan Hartmann

Partner